Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 224 | 2024 | 5034 | 13.670 |
Why?
|
Warfarin | 116 | 2023 | 1496 | 9.850 |
Why?
|
Anticoagulants | 166 | 2024 | 4599 | 9.080 |
Why?
|
Stroke | 146 | 2024 | 9981 | 6.540 |
Why?
|
Hemorrhage | 62 | 2023 | 3461 | 2.830 |
Why?
|
Intracranial Hemorrhages | 16 | 2024 | 855 | 2.480 |
Why?
|
International Normalized Ratio | 24 | 2021 | 367 | 2.450 |
Why?
|
Vitamin K | 31 | 2023 | 295 | 2.360 |
Why?
|
Blood Coagulation | 16 | 2021 | 1127 | 2.360 |
Why?
|
Embolism | 27 | 2021 | 408 | 2.320 |
Why?
|
Brain Ischemia | 21 | 2019 | 3265 | 2.320 |
Why?
|
Thromboembolism | 21 | 2018 | 986 | 2.150 |
Why?
|
Morpholines | 26 | 2021 | 571 | 1.970 |
Why?
|
Smoking Cessation | 18 | 2023 | 2071 | 1.840 |
Why?
|
Thiophenes | 25 | 2021 | 588 | 1.770 |
Why?
|
Anti-Arrhythmia Agents | 16 | 2021 | 789 | 1.700 |
Why?
|
Registries | 41 | 2023 | 8089 | 1.370 |
Why?
|
Administration, Oral | 53 | 2023 | 3913 | 1.360 |
Why?
|
Cerebrovascular Disorders | 22 | 2013 | 1504 | 1.320 |
Why?
|
Aged | 269 | 2024 | 163280 | 1.290 |
Why?
|
Fibrinolytic Agents | 17 | 2018 | 2158 | 1.230 |
Why?
|
Risk Assessment | 48 | 2022 | 23338 | 1.170 |
Why?
|
Sciatica | 12 | 2006 | 98 | 1.110 |
Why?
|
Risk Factors | 150 | 2024 | 72290 | 1.090 |
Why?
|
Community-Acquired Infections | 27 | 2002 | 465 | 1.030 |
Why?
|
Pneumonia | 31 | 2002 | 2133 | 1.030 |
Why?
|
Aged, 80 and over | 128 | 2022 | 57776 | 1.030 |
Why?
|
Male | 312 | 2024 | 350118 | 1.000 |
Why?
|
Female | 322 | 2024 | 380194 | 0.970 |
Why?
|
Drug Monitoring | 8 | 2019 | 956 | 0.940 |
Why?
|
Humans | 426 | 2024 | 744343 | 0.880 |
Why?
|
Spinal Stenosis | 9 | 2005 | 255 | 0.810 |
Why?
|
Patient Discharge | 17 | 2023 | 3313 | 0.800 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2019 | 1130 | 0.790 |
Why?
|
Aspirin | 25 | 2018 | 3282 | 0.760 |
Why?
|
Atrial Flutter | 5 | 2017 | 263 | 0.750 |
Why?
|
Middle Aged | 212 | 2023 | 213383 | 0.740 |
Why?
|
Electric Countershock | 9 | 2020 | 534 | 0.730 |
Why?
|
Coagulants | 1 | 2020 | 49 | 0.730 |
Why?
|
Muscle Rigidity | 1 | 2019 | 35 | 0.720 |
Why?
|
Factor VIIa | 1 | 2020 | 101 | 0.700 |
Why?
|
Treatment Outcome | 100 | 2024 | 63114 | 0.680 |
Why?
|
Defibrillators, Implantable | 7 | 2018 | 1440 | 0.660 |
Why?
|
Blood Coagulation Factors | 2 | 2020 | 355 | 0.660 |
Why?
|
Lumbar Vertebrae | 11 | 2006 | 1848 | 0.650 |
Why?
|
Diabetes Mellitus | 15 | 2022 | 5751 | 0.650 |
Why?
|
Follow-Up Studies | 63 | 2020 | 39050 | 0.640 |
Why?
|
Primary Health Care | 15 | 2023 | 4558 | 0.640 |
Why?
|
Thoracic Wall | 1 | 2019 | 203 | 0.610 |
Why?
|
Time Factors | 58 | 2021 | 40075 | 0.610 |
Why?
|
California | 12 | 2019 | 1402 | 0.610 |
Why?
|
Incidence | 39 | 2023 | 20947 | 0.600 |
Why?
|
Plasma | 2 | 2020 | 575 | 0.600 |
Why?
|
Naloxone | 1 | 2019 | 367 | 0.590 |
Why?
|
Venous Thromboembolism | 8 | 2021 | 1671 | 0.590 |
Why?
|
Ambulatory Care | 13 | 2016 | 2708 | 0.580 |
Why?
|
Reminder Systems | 2 | 2017 | 371 | 0.580 |
Why?
|
Crotalid Venoms | 1 | 2016 | 28 | 0.570 |
Why?
|
Hospitalization | 32 | 2022 | 10262 | 0.570 |
Why?
|
Electrocardiography | 13 | 2023 | 6442 | 0.560 |
Why?
|
Drug Dosage Calculations | 3 | 2018 | 114 | 0.560 |
Why?
|
Counseling | 8 | 2022 | 1523 | 0.550 |
Why?
|
Renal Insufficiency, Chronic | 8 | 2023 | 2208 | 0.530 |
Why?
|
Withholding Treatment | 4 | 2021 | 599 | 0.530 |
Why?
|
Prospective Studies | 87 | 2022 | 53288 | 0.530 |
Why?
|
Age Factors | 32 | 2021 | 18370 | 0.520 |
Why?
|
Natural Language Processing | 2 | 2024 | 1041 | 0.510 |
Why?
|
Platelet Aggregation Inhibitors | 15 | 2020 | 3068 | 0.510 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 562 | 0.510 |
Why?
|
Cohort Studies | 55 | 2023 | 40561 | 0.510 |
Why?
|
Diskectomy | 6 | 2005 | 206 | 0.500 |
Why?
|
Tobacco Use Disorder | 5 | 2018 | 688 | 0.480 |
Why?
|
Comorbidity | 29 | 2023 | 10388 | 0.480 |
Why?
|
United States | 68 | 2024 | 69872 | 0.480 |
Why?
|
Cerebral Hemorrhage | 8 | 2024 | 2647 | 0.450 |
Why?
|
Pyridones | 6 | 2021 | 712 | 0.450 |
Why?
|
Blood Glucose | 14 | 2016 | 6256 | 0.450 |
Why?
|
Sweden | 3 | 2024 | 1345 | 0.440 |
Why?
|
Double-Blind Method | 32 | 2021 | 12026 | 0.440 |
Why?
|
Respiratory Tract Infections | 4 | 2003 | 961 | 0.430 |
Why?
|
Research Design | 9 | 2021 | 5987 | 0.400 |
Why?
|
Adult | 117 | 2024 | 214055 | 0.390 |
Why?
|
Mass Screening | 10 | 2022 | 5255 | 0.390 |
Why?
|
Proportional Hazards Models | 23 | 2019 | 12354 | 0.370 |
Why?
|
Patient Satisfaction | 13 | 2019 | 3396 | 0.370 |
Why?
|
Drug Prescriptions | 5 | 2018 | 1637 | 0.360 |
Why?
|
Guideline Adherence | 6 | 2019 | 2266 | 0.360 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2019 | 3923 | 0.360 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2022 | 585 | 0.360 |
Why?
|
Pregnancy in Adolescence | 5 | 1998 | 158 | 0.350 |
Why?
|
Electronic Health Records | 10 | 2024 | 4468 | 0.350 |
Why?
|
Kidney Function Tests | 4 | 2021 | 684 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 23 | 2018 | 9959 | 0.350 |
Why?
|
Thrombolytic Therapy | 5 | 2018 | 2161 | 0.350 |
Why?
|
Multivariate Analysis | 22 | 2021 | 12245 | 0.340 |
Why?
|
Drug Utilization | 6 | 2004 | 1183 | 0.340 |
Why?
|
Quality of Life | 24 | 2020 | 12804 | 0.340 |
Why?
|
Predictive Value of Tests | 20 | 2020 | 15076 | 0.340 |
Why?
|
Prevalence | 24 | 2023 | 15226 | 0.330 |
Why?
|
Intracranial Embolism | 6 | 2019 | 202 | 0.330 |
Why?
|
Kazakhstan | 3 | 2023 | 14 | 0.320 |
Why?
|
Logistic Models | 26 | 2019 | 13408 | 0.320 |
Why?
|
Ischemic Attack, Transient | 8 | 2018 | 935 | 0.320 |
Why?
|
Antithrombins | 4 | 2021 | 304 | 0.310 |
Why?
|
Telephone | 5 | 2021 | 617 | 0.310 |
Why?
|
Smoking | 8 | 2017 | 8987 | 0.300 |
Why?
|
Case-Control Studies | 18 | 2024 | 21746 | 0.300 |
Why?
|
Pyrazoles | 6 | 2021 | 1972 | 0.300 |
Why?
|
Prognosis | 23 | 2019 | 29063 | 0.300 |
Why?
|
Severity of Illness Index | 27 | 2021 | 15540 | 0.300 |
Why?
|
Boston | 18 | 2020 | 9313 | 0.300 |
Why?
|
Workers' Compensation | 4 | 2006 | 152 | 0.290 |
Why?
|
Comparative Effectiveness Research | 5 | 2023 | 681 | 0.290 |
Why?
|
Retrospective Studies | 47 | 2023 | 77449 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2019 | 10943 | 0.290 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 2376 | 0.290 |
Why?
|
Length of Stay | 16 | 2017 | 6309 | 0.290 |
Why?
|
Quality-Adjusted Life Years | 6 | 2020 | 1683 | 0.290 |
Why?
|
Manipulation, Orthopedic | 2 | 1996 | 43 | 0.290 |
Why?
|
Aftercare | 4 | 2023 | 866 | 0.280 |
Why?
|
Heart Rate | 5 | 2023 | 4091 | 0.280 |
Why?
|
Europe | 6 | 2020 | 3339 | 0.280 |
Why?
|
Digoxin | 3 | 2015 | 250 | 0.270 |
Why?
|
Venous Thrombosis | 3 | 2021 | 1239 | 0.270 |
Why?
|
Oligosaccharides | 1 | 2008 | 414 | 0.270 |
Why?
|
Factor Xa | 4 | 2015 | 162 | 0.270 |
Why?
|
Catheter Ablation | 5 | 2020 | 2758 | 0.260 |
Why?
|
Amiodarone | 2 | 2019 | 212 | 0.260 |
Why?
|
Survival Rate | 15 | 2021 | 12788 | 0.260 |
Why?
|
Cardiovascular Diseases | 14 | 2022 | 15165 | 0.260 |
Why?
|
Polypharmacy | 5 | 2019 | 294 | 0.260 |
Why?
|
Databases, Factual | 7 | 2021 | 7729 | 0.260 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 265 | 0.260 |
Why?
|
Asia | 3 | 2020 | 610 | 0.250 |
Why?
|
Abdominal Injuries | 2 | 2005 | 352 | 0.250 |
Why?
|
Bupropion | 1 | 2006 | 303 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 20 | 2004 | 11725 | 0.250 |
Why?
|
Societies, Medical | 3 | 2013 | 3743 | 0.250 |
Why?
|
Decision Support Techniques | 7 | 2019 | 1956 | 0.240 |
Why?
|
Evidence-Based Medicine | 5 | 2012 | 3610 | 0.240 |
Why?
|
Cause of Death | 8 | 2019 | 3584 | 0.240 |
Why?
|
Pennsylvania | 9 | 2020 | 613 | 0.240 |
Why?
|
Wounds, Nonpenetrating | 3 | 2005 | 794 | 0.240 |
Why?
|
Odds Ratio | 14 | 2017 | 9849 | 0.230 |
Why?
|
Hypertension | 15 | 2022 | 8480 | 0.230 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 503 | 0.230 |
Why?
|
Cross-Over Studies | 2 | 2021 | 2029 | 0.230 |
Why?
|
Office Visits | 5 | 2019 | 598 | 0.220 |
Why?
|
Myocardial Infarction | 12 | 2022 | 11727 | 0.220 |
Why?
|
Residence Characteristics | 1 | 2013 | 2050 | 0.220 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.220 |
Why?
|
Medication Adherence | 3 | 2019 | 2063 | 0.220 |
Why?
|
Patient Admission | 4 | 2000 | 1380 | 0.220 |
Why?
|
Disability Evaluation | 7 | 2017 | 1827 | 0.220 |
Why?
|
Hospitals, Teaching | 5 | 2012 | 1179 | 0.210 |
Why?
|
Drug Therapy, Combination | 12 | 2019 | 6489 | 0.210 |
Why?
|
Outpatient Clinics, Hospital | 4 | 2013 | 392 | 0.210 |
Why?
|
Factor V | 1 | 2003 | 178 | 0.210 |
Why?
|
Kidney | 4 | 2020 | 7186 | 0.210 |
Why?
|
North America | 3 | 2015 | 1249 | 0.210 |
Why?
|
Angina, Unstable | 1 | 2006 | 926 | 0.210 |
Why?
|
Latin America | 3 | 2021 | 381 | 0.200 |
Why?
|
Massachusetts | 15 | 2019 | 8663 | 0.200 |
Why?
|
Thrombosis | 4 | 2009 | 2968 | 0.200 |
Why?
|
Drug Administration Schedule | 10 | 2020 | 4933 | 0.200 |
Why?
|
Biomedical Research | 3 | 2021 | 3309 | 0.200 |
Why?
|
Glucose Tolerance Test | 3 | 2002 | 1150 | 0.200 |
Why?
|
Patient Compliance | 7 | 2014 | 2684 | 0.200 |
Why?
|
Calcium Channel Blockers | 3 | 2017 | 690 | 0.200 |
Why?
|
Software Validation | 1 | 2021 | 59 | 0.190 |
Why?
|
Meningitis, Viral | 1 | 2021 | 50 | 0.190 |
Why?
|
Data Collection | 5 | 2014 | 3341 | 0.190 |
Why?
|
Risk | 19 | 2016 | 9687 | 0.190 |
Why?
|
Propensity Score | 5 | 2019 | 1781 | 0.190 |
Why?
|
Healthcare Disparities | 2 | 2014 | 3158 | 0.190 |
Why?
|
Cross-Sectional Studies | 21 | 2023 | 25043 | 0.190 |
Why?
|
Nicotine | 2 | 2023 | 681 | 0.190 |
Why?
|
Renal Insufficiency | 2 | 2021 | 804 | 0.190 |
Why?
|
HIV-1 | 2 | 2017 | 6939 | 0.190 |
Why?
|
Aortic Valve Insufficiency | 2 | 2016 | 579 | 0.190 |
Why?
|
Hyperglycemia | 5 | 2004 | 1373 | 0.190 |
Why?
|
Recurrence | 9 | 2021 | 8340 | 0.190 |
Why?
|
Markov Chains | 4 | 2018 | 969 | 0.190 |
Why?
|
Anticonvulsants | 2 | 2021 | 1916 | 0.180 |
Why?
|
Patient Participation | 3 | 2020 | 1457 | 0.180 |
Why?
|
Tobacco Use Cessation | 1 | 2021 | 95 | 0.180 |
Why?
|
Emergency Service, Hospital | 8 | 2019 | 7659 | 0.180 |
Why?
|
Atrial Appendage | 1 | 2024 | 283 | 0.180 |
Why?
|
Infant, Premature, Diseases | 1 | 2006 | 706 | 0.180 |
Why?
|
Sex Factors | 12 | 2018 | 10397 | 0.180 |
Why?
|
Nova Scotia | 5 | 2000 | 34 | 0.180 |
Why?
|
Intention to Treat Analysis | 6 | 2021 | 426 | 0.180 |
Why?
|
Neoplasms | 8 | 2024 | 21683 | 0.170 |
Why?
|
Heart Valve Diseases | 2 | 2017 | 1073 | 0.170 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 302 | 0.170 |
Why?
|
Creatine Kinase | 1 | 2021 | 694 | 0.170 |
Why?
|
Meningitis, Bacterial | 1 | 2021 | 218 | 0.170 |
Why?
|
Patient Transfer | 2 | 2018 | 761 | 0.170 |
Why?
|
beta-Alanine | 3 | 2013 | 74 | 0.170 |
Why?
|
Anti-Bacterial Agents | 9 | 2017 | 7181 | 0.170 |
Why?
|
Antihypertensive Agents | 3 | 2005 | 2046 | 0.160 |
Why?
|
Hypoglycemic Agents | 4 | 2006 | 2872 | 0.160 |
Why?
|
Spleen | 1 | 2005 | 2362 | 0.160 |
Why?
|
South Africa | 2 | 2015 | 1731 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2118 | 0.160 |
Why?
|
Continuity of Patient Care | 2 | 2018 | 1049 | 0.160 |
Why?
|
Hospitals, Urban | 1 | 2000 | 499 | 0.160 |
Why?
|
Mortality | 6 | 2021 | 2864 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 8 | 2018 | 6538 | 0.160 |
Why?
|
Heart Failure | 12 | 2022 | 10900 | 0.160 |
Why?
|
Treatment Refusal | 2 | 2003 | 421 | 0.160 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2538 | 0.160 |
Why?
|
Monte Carlo Method | 3 | 2018 | 1254 | 0.160 |
Why?
|
Cost-Benefit Analysis | 10 | 2022 | 5391 | 0.160 |
Why?
|
Analgesics, Non-Narcotic | 2 | 1998 | 365 | 0.160 |
Why?
|
Motivation | 4 | 2015 | 1971 | 0.150 |
Why?
|
Basal Metabolism | 1 | 2018 | 168 | 0.150 |
Why?
|
Glucose Intolerance | 3 | 2000 | 577 | 0.150 |
Why?
|
Encephalitis | 1 | 2021 | 423 | 0.150 |
Why?
|
Electronic Prescribing | 1 | 2018 | 121 | 0.150 |
Why?
|
Physicians | 4 | 2018 | 4567 | 0.150 |
Why?
|
Hospitals, General | 3 | 2017 | 749 | 0.150 |
Why?
|
Acetaminophen | 2 | 1998 | 545 | 0.150 |
Why?
|
Leiomyoma | 1 | 2022 | 730 | 0.150 |
Why?
|
Insurance, Health | 5 | 2017 | 2494 | 0.150 |
Why?
|
Drug Substitution | 3 | 2016 | 281 | 0.150 |
Why?
|
Speech Recognition Software | 1 | 2017 | 72 | 0.150 |
Why?
|
Models, Cardiovascular | 3 | 2018 | 996 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2020 | 1813 | 0.140 |
Why?
|
Automation | 2 | 2020 | 584 | 0.140 |
Why?
|
Disease Management | 3 | 2020 | 2459 | 0.140 |
Why?
|
Tobacco Industry | 1 | 1997 | 126 | 0.140 |
Why?
|
Adolescent | 41 | 2021 | 85781 | 0.140 |
Why?
|
Space Flight | 1 | 2018 | 188 | 0.140 |
Why?
|
Attitude | 2 | 2023 | 776 | 0.140 |
Why?
|
Small-Area Analysis | 2 | 2014 | 55 | 0.140 |
Why?
|
Syndrome | 2 | 2019 | 3251 | 0.140 |
Why?
|
Malawi | 1 | 2017 | 282 | 0.140 |
Why?
|
Forecasting | 4 | 2013 | 2951 | 0.140 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1772 | 0.130 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1188 | 0.130 |
Why?
|
Aging | 4 | 2013 | 8664 | 0.130 |
Why?
|
Medicare | 6 | 2024 | 6566 | 0.130 |
Why?
|
Intention | 1 | 2018 | 341 | 0.130 |
Why?
|
Telemetry | 1 | 2017 | 205 | 0.130 |
Why?
|
Self-Help Groups | 1 | 1997 | 190 | 0.130 |
Why?
|
Organizational Policy | 2 | 2000 | 429 | 0.130 |
Why?
|
Diabetes Complications | 2 | 1996 | 1359 | 0.130 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1622 | 0.130 |
Why?
|
Disease Progression | 6 | 2019 | 13284 | 0.130 |
Why?
|
Comprehensive Health Care | 1 | 1996 | 127 | 0.130 |
Why?
|
Laminectomy | 1 | 1996 | 234 | 0.130 |
Why?
|
Mitral Valve Insufficiency | 2 | 2016 | 1422 | 0.130 |
Why?
|
Myocardial Ischemia | 3 | 2022 | 2148 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2019 | 685 | 0.130 |
Why?
|
Off-Label Use | 1 | 2016 | 169 | 0.130 |
Why?
|
Nicotinic Agonists | 1 | 2017 | 271 | 0.130 |
Why?
|
Multicenter Studies as Topic | 6 | 2020 | 1677 | 0.130 |
Why?
|
Employment | 3 | 2006 | 1132 | 0.130 |
Why?
|
Algorithms | 7 | 2024 | 13881 | 0.130 |
Why?
|
Hyperinsulinism | 4 | 2000 | 415 | 0.130 |
Why?
|
Health Literacy | 2 | 2017 | 414 | 0.130 |
Why?
|
Dyslipidemias | 1 | 2022 | 849 | 0.130 |
Why?
|
Cough | 1 | 1998 | 555 | 0.130 |
Why?
|
Insulin Resistance | 5 | 2006 | 3864 | 0.120 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1179 | 0.120 |
Why?
|
Substance-Related Disorders | 4 | 2017 | 4258 | 0.120 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2008 | 339 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 367 | 0.120 |
Why?
|
Decision Making | 7 | 2018 | 3887 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 822 | 0.120 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 2 | 1994 | 139 | 0.120 |
Why?
|
Drug Labeling | 1 | 2016 | 233 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2001 | 979 | 0.120 |
Why?
|
Drug Resistance, Bacterial | 1 | 2002 | 1035 | 0.120 |
Why?
|
Family Planning Services | 1 | 1997 | 263 | 0.120 |
Why?
|
Adolescent Health Services | 1 | 1996 | 215 | 0.120 |
Why?
|
Program Evaluation | 3 | 2009 | 2488 | 0.120 |
Why?
|
HIV Infections | 3 | 2017 | 16718 | 0.120 |
Why?
|
Maine | 6 | 2006 | 139 | 0.120 |
Why?
|
Occupational Diseases | 2 | 2000 | 1471 | 0.120 |
Why?
|
Benzimidazoles | 3 | 2013 | 850 | 0.120 |
Why?
|
Hospitals, Municipal | 1 | 1993 | 19 | 0.120 |
Why?
|
Age Distribution | 5 | 2020 | 2902 | 0.120 |
Why?
|
Monitoring, Physiologic | 5 | 2012 | 1738 | 0.120 |
Why?
|
Cluster Analysis | 2 | 2018 | 2715 | 0.120 |
Why?
|
Therapeutic Human Experimentation | 1 | 1993 | 43 | 0.120 |
Why?
|
Heart Atria | 3 | 2016 | 1357 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1513 | 0.110 |
Why?
|
Thiazoles | 2 | 2020 | 1483 | 0.110 |
Why?
|
Diabetic Retinopathy | 5 | 2002 | 1210 | 0.110 |
Why?
|
Attitude to Health | 4 | 2017 | 2052 | 0.110 |
Why?
|
Chi-Square Distribution | 8 | 2017 | 3508 | 0.110 |
Why?
|
Mammals | 1 | 2018 | 1143 | 0.110 |
Why?
|
South America | 1 | 2013 | 181 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 1392 | 0.110 |
Why?
|
Regression Analysis | 6 | 2016 | 6459 | 0.110 |
Why?
|
Pyridines | 4 | 2020 | 2825 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 545 | 0.110 |
Why?
|
Awareness | 1 | 2017 | 640 | 0.110 |
Why?
|
Secondary Prevention | 3 | 2023 | 1530 | 0.110 |
Why?
|
Survival Analysis | 7 | 2014 | 10252 | 0.110 |
Why?
|
Heart Conduction System | 1 | 2018 | 1047 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 591 | 0.110 |
Why?
|
Liver | 2 | 2005 | 7474 | 0.110 |
Why?
|
Managed Care Programs | 1 | 1998 | 950 | 0.100 |
Why?
|
Cost of Illness | 3 | 2019 | 1859 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2004 | 1240 | 0.100 |
Why?
|
Coronary Artery Disease | 5 | 2019 | 6487 | 0.100 |
Why?
|
Pacemaker, Artificial | 5 | 2012 | 816 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 602 | 0.100 |
Why?
|
Appointments and Schedules | 1 | 2016 | 417 | 0.100 |
Why?
|
Adolescent Behavior | 2 | 1997 | 1151 | 0.100 |
Why?
|
Triglycerides | 5 | 2001 | 2454 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2019 | 595 | 0.100 |
Why?
|
Immunization | 1 | 1996 | 1256 | 0.100 |
Why?
|
Photoplethysmography | 2 | 2022 | 56 | 0.100 |
Why?
|
Depression | 4 | 2018 | 7766 | 0.100 |
Why?
|
Vision Screening | 1 | 1992 | 66 | 0.100 |
Why?
|
Sinusitis | 3 | 2005 | 923 | 0.100 |
Why?
|
Sex Distribution | 5 | 2015 | 2297 | 0.100 |
Why?
|
Creatinine | 5 | 2018 | 1919 | 0.100 |
Why?
|
Population Surveillance | 2 | 2013 | 2616 | 0.100 |
Why?
|
Heparin | 3 | 2020 | 1637 | 0.100 |
Why?
|
Hospital Mortality | 4 | 2018 | 5317 | 0.100 |
Why?
|
Maternal Health Services | 1 | 1996 | 455 | 0.100 |
Why?
|
Health Care Surveys | 5 | 2004 | 2453 | 0.100 |
Why?
|
Intracranial Thrombosis | 2 | 2009 | 113 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2018 | 1573 | 0.100 |
Why?
|
Low Back Pain | 5 | 2005 | 956 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 3 | 2018 | 2268 | 0.090 |
Why?
|
Ischemia | 1 | 2019 | 1907 | 0.090 |
Why?
|
Acute Disease | 5 | 2016 | 7149 | 0.090 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2023 | 314 | 0.090 |
Why?
|
Atrial Premature Complexes | 1 | 2009 | 17 | 0.090 |
Why?
|
Socioeconomic Factors | 9 | 2017 | 7785 | 0.090 |
Why?
|
Vulnerable Populations | 1 | 2016 | 687 | 0.090 |
Why?
|
Communication Barriers | 1 | 2013 | 398 | 0.090 |
Why?
|
Antifibrinolytic Agents | 3 | 2014 | 254 | 0.090 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2002 | 127 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3798 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 500 | 0.090 |
Why?
|
Leg | 2 | 2005 | 1116 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7279 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.090 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5137 | 0.090 |
Why?
|
Substance Abuse, Intravenous | 2 | 1993 | 525 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 1364 | 0.080 |
Why?
|
Linear Models | 4 | 2013 | 5952 | 0.080 |
Why?
|
Parental Consent | 1 | 2009 | 62 | 0.080 |
Why?
|
Prenatal Care | 1 | 1996 | 1092 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 3 | 2019 | 3537 | 0.080 |
Why?
|
Hyperlipidemias | 3 | 2019 | 789 | 0.080 |
Why?
|
Accidental Falls | 1 | 2016 | 1062 | 0.080 |
Why?
|
Inpatients | 1 | 2000 | 2518 | 0.080 |
Why?
|
Fasting | 5 | 2002 | 1593 | 0.080 |
Why?
|
Infant | 7 | 2023 | 35136 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4371 | 0.080 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.080 |
Why?
|
Herpes Genitalis | 1 | 2009 | 141 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2859 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1439 | 0.080 |
Why?
|
Diet | 2 | 2004 | 7939 | 0.080 |
Why?
|
Ticlopidine | 4 | 2016 | 899 | 0.080 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2170 | 0.080 |
Why?
|
Viral Load | 1 | 2017 | 3299 | 0.080 |
Why?
|
Coronary Disease | 7 | 2016 | 6077 | 0.080 |
Why?
|
Life Style | 3 | 2023 | 3835 | 0.080 |
Why?
|
Health Status | 7 | 2020 | 4034 | 0.070 |
Why?
|
Mental Disorders | 2 | 2021 | 6600 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2690 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2004 | 3843 | 0.070 |
Why?
|
Outpatients | 3 | 2020 | 1486 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 666 | 0.070 |
Why?
|
Trauma Centers | 2 | 2017 | 890 | 0.070 |
Why?
|
Drug Interactions | 3 | 2021 | 1460 | 0.070 |
Why?
|
Hypercholesterolemia | 2 | 2003 | 1151 | 0.070 |
Why?
|
Proteinuria | 1 | 2009 | 658 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1420 | 0.070 |
Why?
|
Hospitals, University | 2 | 1998 | 571 | 0.070 |
Why?
|
Ovarian Neoplasms | 2 | 1994 | 4838 | 0.070 |
Why?
|
Health Maintenance Organizations | 2 | 2017 | 642 | 0.070 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2006 | 66 | 0.070 |
Why?
|
Cocaine | 1 | 1991 | 1007 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 1996 | 3336 | 0.070 |
Why?
|
Splenic Rupture | 1 | 2005 | 26 | 0.070 |
Why?
|
Health Services | 1 | 2011 | 758 | 0.070 |
Why?
|
Postoperative Complications | 7 | 2020 | 15295 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2018 | 3748 | 0.060 |
Why?
|
Food Supply | 1 | 2011 | 524 | 0.060 |
Why?
|
Contraception Behavior | 2 | 1998 | 185 | 0.060 |
Why?
|
Recovery of Function | 3 | 2020 | 2925 | 0.060 |
Why?
|
Pain | 3 | 2022 | 4986 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2005 | 20129 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2065 | 0.060 |
Why?
|
Neonatal Screening | 1 | 2009 | 591 | 0.060 |
Why?
|
ROC Curve | 4 | 2020 | 3527 | 0.060 |
Why?
|
Intensive Care, Neonatal | 1 | 2006 | 198 | 0.060 |
Why?
|
Malnutrition | 1 | 2011 | 625 | 0.060 |
Why?
|
Probability | 3 | 2004 | 2505 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 2 | 2011 | 3022 | 0.060 |
Why?
|
Hospitals | 3 | 2022 | 3952 | 0.060 |
Why?
|
Kyrgyzstan | 1 | 2023 | 3 | 0.060 |
Why?
|
Needs Assessment | 1 | 2010 | 1147 | 0.060 |
Why?
|
Treatment Failure | 2 | 2002 | 2618 | 0.060 |
Why?
|
Language | 1 | 2013 | 1471 | 0.060 |
Why?
|
Tracheostomy | 1 | 2007 | 401 | 0.060 |
Why?
|
Blood Pressure | 6 | 2018 | 8554 | 0.060 |
Why?
|
Mesentery | 1 | 2004 | 205 | 0.060 |
Why?
|
Patient Selection | 4 | 2017 | 4215 | 0.060 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13989 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2009 | 780 | 0.060 |
Why?
|
Anxiety | 1 | 2018 | 4297 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2015 | 1797 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3047 | 0.060 |
Why?
|
Telemedicine | 2 | 2021 | 2872 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.060 |
Why?
|
Infant, Small for Gestational Age | 1 | 2006 | 440 | 0.060 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2006 | 406 | 0.060 |
Why?
|
Morbidity | 2 | 2019 | 1769 | 0.060 |
Why?
|
Craniocerebral Trauma | 1 | 2007 | 482 | 0.060 |
Why?
|
Cholesterol, HDL | 3 | 2000 | 1814 | 0.060 |
Why?
|
Hemoglobinometry | 1 | 2002 | 35 | 0.060 |
Why?
|
Lung | 3 | 2018 | 9856 | 0.060 |
Why?
|
Sepsis | 3 | 2013 | 2593 | 0.050 |
Why?
|
Fever | 1 | 1990 | 1616 | 0.050 |
Why?
|
Research Support as Topic | 2 | 2009 | 705 | 0.050 |
Why?
|
Statistics as Topic | 4 | 1998 | 2373 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2005 | 14722 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1387 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2006 | 570 | 0.050 |
Why?
|
Deglutition Disorders | 1 | 2007 | 605 | 0.050 |
Why?
|
Bronchitis, Chronic | 1 | 2002 | 62 | 0.050 |
Why?
|
Coronary Care Units | 2 | 1991 | 214 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 200 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2004 | 511 | 0.050 |
Why?
|
Internationality | 2 | 2018 | 1003 | 0.050 |
Why?
|
Intensive Care Units | 5 | 2002 | 3679 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2006 | 1681 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2004 | 2971 | 0.050 |
Why?
|
Neisseria meningitidis | 1 | 2021 | 109 | 0.050 |
Why?
|
Pregnancy | 8 | 2006 | 29144 | 0.050 |
Why?
|
Pneumonia, Bacterial | 2 | 2001 | 316 | 0.050 |
Why?
|
Enterovirus | 1 | 2021 | 64 | 0.050 |
Why?
|
Dengue Virus | 1 | 2003 | 204 | 0.050 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2018 | 859 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2003 | 468 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 317 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11031 | 0.050 |
Why?
|
Clinical Trials as Topic | 5 | 2009 | 7913 | 0.050 |
Why?
|
Insurance Claim Review | 1 | 2005 | 720 | 0.050 |
Why?
|
Military Personnel | 1 | 2009 | 1133 | 0.050 |
Why?
|
Tennessee | 1 | 2020 | 117 | 0.050 |
Why?
|
Patient Education as Topic | 3 | 2017 | 2278 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1584 | 0.050 |
Why?
|
Reproducibility of Results | 8 | 2017 | 19905 | 0.050 |
Why?
|
Clinical Coding | 1 | 2021 | 171 | 0.040 |
Why?
|
Young Adult | 8 | 2021 | 56430 | 0.040 |
Why?
|
Patient Care Team | 2 | 2018 | 2531 | 0.040 |
Why?
|
Fentanyl | 1 | 2022 | 410 | 0.040 |
Why?
|
Thyroxine | 1 | 2003 | 667 | 0.040 |
Why?
|
Comprehension | 2 | 2017 | 610 | 0.040 |
Why?
|
Nausea | 1 | 2022 | 673 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2002 | 269 | 0.040 |
Why?
|
Middle East | 1 | 2020 | 219 | 0.040 |
Why?
|
Family Practice | 2 | 2004 | 516 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2007 | 931 | 0.040 |
Why?
|
Dengue | 1 | 2003 | 256 | 0.040 |
Why?
|
Glycosuria | 3 | 1989 | 43 | 0.040 |
Why?
|
Streptococcus pneumoniae | 2 | 2002 | 714 | 0.040 |
Why?
|
Medical Staff, Hospital | 2 | 2003 | 603 | 0.040 |
Why?
|
Hemostasis | 2 | 2000 | 458 | 0.040 |
Why?
|
Sensation | 1 | 2001 | 336 | 0.040 |
Why?
|
Psychometrics | 2 | 2005 | 3002 | 0.040 |
Why?
|
Rectovaginal Fistula | 1 | 1998 | 11 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2001 | 275 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5788 | 0.040 |
Why?
|
Postoperative Period | 2 | 2019 | 1842 | 0.040 |
Why?
|
Heart Valves | 1 | 2000 | 291 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2003 | 658 | 0.040 |
Why?
|
Cholesterol | 3 | 2003 | 2917 | 0.040 |
Why?
|
Physicians, Women | 1 | 2004 | 486 | 0.040 |
Why?
|
Self Care | 2 | 1998 | 786 | 0.040 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2017 | 430 | 0.040 |
Why?
|
Homocysteine | 1 | 2001 | 647 | 0.040 |
Why?
|
Birth Intervals | 1 | 1998 | 51 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 35421 | 0.040 |
Why?
|
Social Support | 2 | 2018 | 2118 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2009 | 2149 | 0.040 |
Why?
|
Birth Weight | 1 | 2006 | 2069 | 0.040 |
Why?
|
Education | 1 | 2021 | 543 | 0.040 |
Why?
|
Critical Pathways | 1 | 2001 | 476 | 0.040 |
Why?
|
Specialization | 2 | 2004 | 777 | 0.040 |
Why?
|
Blood Transfusion | 2 | 2014 | 1301 | 0.040 |
Why?
|
Simplexvirus | 1 | 2021 | 802 | 0.040 |
Why?
|
Insulin | 4 | 2001 | 6580 | 0.040 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.040 |
Why?
|
New York | 1 | 2000 | 886 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8642 | 0.040 |
Why?
|
Brain Concussion | 1 | 1988 | 1320 | 0.040 |
Why?
|
Immunotherapy | 1 | 2013 | 4445 | 0.040 |
Why?
|
Health Services Research | 3 | 2013 | 1836 | 0.040 |
Why?
|
Obesity | 5 | 2022 | 12745 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2021 | 594 | 0.040 |
Why?
|
Colorado | 1 | 1997 | 163 | 0.040 |
Why?
|
Brain | 1 | 2024 | 26385 | 0.040 |
Why?
|
Quebec | 1 | 1996 | 134 | 0.040 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.040 |
Why?
|
Diltiazem | 1 | 2017 | 133 | 0.040 |
Why?
|
Child | 8 | 2021 | 77709 | 0.040 |
Why?
|
Fertilization | 1 | 1998 | 196 | 0.040 |
Why?
|
Verapamil | 1 | 2017 | 244 | 0.040 |
Why?
|
Prothrombin Time | 2 | 1994 | 119 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2291 | 0.040 |
Why?
|
Confidentiality | 1 | 2021 | 612 | 0.040 |
Why?
|
Body Mass Index | 4 | 2017 | 12720 | 0.040 |
Why?
|
Epidemiologic Factors | 1 | 1996 | 36 | 0.040 |
Why?
|
Pulmonary Edema | 3 | 1989 | 414 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 550 | 0.030 |
Why?
|
Blood Coagulation Tests | 1 | 1997 | 263 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 469 | 0.030 |
Why?
|
Reoperation | 2 | 2005 | 4201 | 0.030 |
Why?
|
Italy | 1 | 2018 | 832 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2788 | 0.030 |
Why?
|
Disabled Persons | 2 | 2006 | 1212 | 0.030 |
Why?
|
Fecal Incontinence | 1 | 1998 | 239 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 1998 | 275 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1170 | 0.030 |
Why?
|
Osteoarthritis | 1 | 2003 | 1036 | 0.030 |
Why?
|
Anal Canal | 1 | 1998 | 376 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5102 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1660 | 0.030 |
Why?
|
Health Care Costs | 2 | 2023 | 3209 | 0.030 |
Why?
|
Parents | 1 | 2009 | 3407 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2000 | 632 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2006 | 3229 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 1997 | 310 | 0.030 |
Why?
|
Internet | 2 | 2009 | 3064 | 0.030 |
Why?
|
New York City | 1 | 2017 | 710 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2004 | 2759 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 1998 | 2886 | 0.030 |
Why?
|
Quality Indicators, Health Care | 2 | 2017 | 1831 | 0.030 |
Why?
|
Intestines | 1 | 2004 | 1924 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2019 | 841 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 1997 | 977 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2004 | 1207 | 0.030 |
Why?
|
Atrial Function, Left | 1 | 2016 | 173 | 0.030 |
Why?
|
Consumer Health Information | 1 | 2017 | 211 | 0.030 |
Why?
|
Streptococcal Infections | 2 | 1998 | 638 | 0.030 |
Why?
|
Quality Control | 1 | 2017 | 841 | 0.030 |
Why?
|
Nephrology | 1 | 2018 | 263 | 0.030 |
Why?
|
Parity | 1 | 1998 | 929 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2000 | 1438 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 851 | 0.030 |
Why?
|
Medical Records | 1 | 2000 | 1413 | 0.030 |
Why?
|
District of Columbia | 1 | 2014 | 157 | 0.030 |
Why?
|
Hospital Costs | 1 | 2000 | 985 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2001 | 985 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1431 | 0.030 |
Why?
|
Medicine | 2 | 2004 | 946 | 0.030 |
Why?
|
Heart | 2 | 2023 | 4467 | 0.030 |
Why?
|
Geography | 1 | 2016 | 669 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 60 | 0.030 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1993 | 148 | 0.030 |
Why?
|
Thrombophilia | 1 | 2016 | 305 | 0.030 |
Why?
|
Diastole | 1 | 2016 | 791 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.030 |
Why?
|
Hematoma, Subdural | 1 | 1994 | 126 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 41006 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1654 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1350 | 0.030 |
Why?
|
Mammography | 1 | 2004 | 2476 | 0.030 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 495 | 0.030 |
Why?
|
Death, Sudden | 1 | 2015 | 302 | 0.030 |
Why?
|
Quality Assurance, Health Care | 2 | 2001 | 2212 | 0.030 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 1681 | 0.030 |
Why?
|
Triage | 2 | 1990 | 976 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1863 | 0.030 |
Why?
|
Cornea | 1 | 2001 | 1524 | 0.030 |
Why?
|
Light Coagulation | 1 | 1992 | 72 | 0.030 |
Why?
|
Alcohol-Related Disorders | 1 | 2014 | 234 | 0.030 |
Why?
|
Cost Savings | 2 | 2012 | 926 | 0.030 |
Why?
|
Commerce | 1 | 1997 | 592 | 0.030 |
Why?
|
Peer Group | 1 | 1997 | 635 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2004 | 2020 | 0.030 |
Why?
|
Perception | 1 | 2018 | 1198 | 0.020 |
Why?
|
Angina Pectoris | 2 | 1989 | 977 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 882 | 0.020 |
Why?
|
Arginine | 1 | 2015 | 944 | 0.020 |
Why?
|
China | 1 | 2017 | 2248 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2009 | 25625 | 0.020 |
Why?
|
Diabetic Foot | 1 | 1994 | 355 | 0.020 |
Why?
|
Health Surveys | 2 | 2017 | 4037 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2418 | 0.020 |
Why?
|
Analgesics | 1 | 2017 | 1040 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 972 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1991 | 919 | 0.020 |
Why?
|
Frail Elderly | 1 | 2015 | 693 | 0.020 |
Why?
|
Palliative Care | 1 | 2005 | 3493 | 0.020 |
Why?
|
Oxygen | 2 | 2017 | 4189 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1534 | 0.020 |
Why?
|
Health Care Rationing | 1 | 1993 | 437 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 3255 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2716 | 0.020 |
Why?
|
Stroke Volume | 2 | 2016 | 5007 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1420 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4328 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1400 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1792 | 0.020 |
Why?
|
Analysis of Variance | 3 | 2009 | 6365 | 0.020 |
Why?
|
Human Experimentation | 1 | 2009 | 127 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 441 | 0.020 |
Why?
|
Myocardium | 2 | 1993 | 4776 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 1990 | 324 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
Thallium | 1 | 1987 | 101 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 984 | 0.020 |
Why?
|
Uremia | 1 | 1988 | 201 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2400 | 0.020 |
Why?
|
Health Resources | 2 | 2004 | 911 | 0.020 |
Why?
|
Chronic Disease | 3 | 2009 | 9146 | 0.020 |
Why?
|
Pregnancy in Diabetics | 1 | 1988 | 179 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2013 | 1462 | 0.020 |
Why?
|
Dipyridamole | 1 | 1987 | 145 | 0.020 |
Why?
|
Cardiac Output | 1 | 1969 | 854 | 0.020 |
Why?
|
Physicians, Family | 1 | 2009 | 345 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3558 | 0.020 |
Why?
|
Epidemiology | 1 | 2009 | 287 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 531 | 0.020 |
Why?
|
Shock, Septic | 1 | 2013 | 775 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1990 | 455 | 0.020 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 1989 | 434 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 481 | 0.020 |
Why?
|
Hemangiosarcoma | 1 | 1988 | 239 | 0.020 |
Why?
|
Radioisotopes | 1 | 1987 | 499 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 1991 | 1364 | 0.020 |
Why?
|
Lisinopril | 1 | 2005 | 54 | 0.020 |
Why?
|
Calcium Channels | 1 | 1989 | 622 | 0.020 |
Why?
|
Financing, Government | 1 | 2009 | 468 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2014 | 1177 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2232 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6622 | 0.020 |
Why?
|
Atenolol | 1 | 2005 | 100 | 0.020 |
Why?
|
Hydrochlorothiazide | 1 | 2005 | 98 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 1998 | 3966 | 0.020 |
Why?
|
Kenya | 1 | 2007 | 685 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1988 | 374 | 0.020 |
Why?
|
Urine | 1 | 1986 | 370 | 0.020 |
Why?
|
Piperazines | 1 | 2015 | 2488 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2004 | 107 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1536 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1983 | 115 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1988 | 952 | 0.010 |
Why?
|
Mentors | 1 | 2009 | 631 | 0.010 |
Why?
|
Eating | 1 | 2011 | 1536 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2013 | 1580 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2007 | 924 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 2016 | 1965 | 0.010 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1985 | 434 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 5102 | 0.010 |
Why?
|
Radiography | 3 | 2001 | 7023 | 0.010 |
Why?
|
Air Conditioning | 1 | 2003 | 50 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 1991 | 1221 | 0.010 |
Why?
|
Patient Readmission | 3 | 1998 | 3114 | 0.010 |
Why?
|
Poverty | 1 | 2014 | 2660 | 0.010 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2005 | 336 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2014 | 1901 | 0.010 |
Why?
|
Nutritional Status | 1 | 2011 | 1609 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2003 | 206 | 0.010 |
Why?
|
Aedes | 1 | 2003 | 100 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1983 | 455 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2006 | 845 | 0.010 |
Why?
|
Texas | 1 | 2003 | 392 | 0.010 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 312 | 0.010 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.010 |
Why?
|
Vitamin K 1 | 1 | 2001 | 48 | 0.010 |
Why?
|
Tetracaine | 1 | 2001 | 35 | 0.010 |
Why?
|
Ultrasonography | 1 | 1994 | 5985 | 0.010 |
Why?
|
Pharmacists | 1 | 2003 | 248 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2004 | 537 | 0.010 |
Why?
|
Clinical Medicine | 1 | 2002 | 147 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1993 | 13033 | 0.010 |
Why?
|
Utilization Review | 1 | 2002 | 392 | 0.010 |
Why?
|
Educational Status | 2 | 1999 | 2540 | 0.010 |
Why?
|
Mexico | 1 | 2003 | 690 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 1993 | 4462 | 0.010 |
Why?
|
Research | 1 | 2009 | 1999 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 661 | 0.010 |
Why?
|
Focus Groups | 1 | 2005 | 1321 | 0.010 |
Why?
|
Efficiency | 1 | 1983 | 462 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 2000 | 181 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 277 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2001 | 383 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1993 | 3110 | 0.010 |
Why?
|
Blotting, Northern | 2 | 1993 | 1581 | 0.010 |
Why?
|
Pelvis | 1 | 2004 | 730 | 0.010 |
Why?
|
Community Health Centers | 1 | 2003 | 430 | 0.010 |
Why?
|
Blood Viscosity | 1 | 2000 | 124 | 0.010 |
Why?
|
Lung Diseases | 1 | 1990 | 1886 | 0.010 |
Why?
|
Leadership | 1 | 2009 | 1357 | 0.010 |
Why?
|
Syncope | 1 | 1982 | 429 | 0.010 |
Why?
|
Complement C1 | 1 | 1979 | 33 | 0.010 |
Why?
|
Lipoproteins, VLDL | 1 | 2000 | 201 | 0.010 |
Why?
|
Immune Complex Diseases | 1 | 1979 | 54 | 0.010 |
Why?
|
Blood | 1 | 2001 | 598 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1988 | 2289 | 0.010 |
Why?
|
Infant, Premature | 1 | 1988 | 2044 | 0.010 |
Why?
|
Emergencies | 1 | 1985 | 1170 | 0.010 |
Why?
|
Fibrinolysis | 1 | 2000 | 322 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2003 | 1344 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2001 | 527 | 0.010 |
Why?
|
Otolaryngology | 1 | 2005 | 645 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 1987 | 1475 | 0.010 |
Why?
|
Oximetry | 1 | 2001 | 471 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2274 | 0.010 |
Why?
|
Quality Improvement | 1 | 2013 | 3749 | 0.010 |
Why?
|
Lidocaine | 1 | 2001 | 544 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2003 | 1537 | 0.010 |
Why?
|
Animals | 4 | 2018 | 168757 | 0.010 |
Why?
|
Bupivacaine | 1 | 2001 | 411 | 0.010 |
Why?
|
Erythromycin | 1 | 1997 | 120 | 0.010 |
Why?
|
Albuminuria | 1 | 2001 | 682 | 0.010 |
Why?
|
Immunocompetence | 1 | 1997 | 137 | 0.010 |
Why?
|
Documentation | 1 | 2003 | 871 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1979 | 517 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 1988 | 1917 | 0.010 |
Why?
|
Rural Population | 1 | 2007 | 2210 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 20822 | 0.010 |
Why?
|
Travel | 1 | 2003 | 788 | 0.010 |
Why?
|
Glomerulonephritis | 1 | 1979 | 372 | 0.010 |
Why?
|
Health Education | 1 | 2003 | 1056 | 0.010 |
Why?
|
Environment | 1 | 2003 | 1124 | 0.010 |
Why?
|
Canada | 1 | 2002 | 2065 | 0.010 |
Why?
|
Manometry | 1 | 1998 | 445 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2003 | 1125 | 0.010 |
Why?
|
Contraceptive Agents, Female | 1 | 1998 | 135 | 0.010 |
Why?
|
Endoscopy | 1 | 2005 | 1785 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2585 | 0.010 |
Why?
|
Lipoproteins | 1 | 2000 | 878 | 0.010 |
Why?
|
Maternal Age | 1 | 1998 | 802 | 0.010 |
Why?
|
Women's Health | 1 | 2004 | 2034 | 0.010 |
Why?
|
Folic Acid | 1 | 2001 | 1300 | 0.010 |
Why?
|
Endosonography | 1 | 1998 | 610 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1988 | 2861 | 0.010 |
Why?
|
Models, Biological | 1 | 1991 | 9583 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18029 | 0.010 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 134 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2000 | 12959 | 0.010 |
Why?
|
Bacteremia | 1 | 2000 | 962 | 0.010 |
Why?
|
Nurses | 1 | 2003 | 2461 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1996 | 338 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 1988 | 2031 | 0.010 |
Why?
|
Prothrombin | 1 | 1993 | 185 | 0.010 |
Why?
|
Pleurisy | 1 | 1993 | 53 | 0.010 |
Why?
|
Pulse | 1 | 1993 | 229 | 0.010 |
Why?
|
Family Characteristics | 1 | 1998 | 1000 | 0.010 |
Why?
|
Hematocrit | 1 | 1994 | 636 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 1993 | 393 | 0.010 |
Why?
|
Diabetic Neuropathies | 2 | 1986 | 400 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2000 | 2356 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 1993 | 404 | 0.010 |
Why?
|
Fluorocarbon Polymers | 1 | 1969 | 16 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1969 | 64 | 0.010 |
Why?
|
Coccidioidomycosis | 1 | 1990 | 36 | 0.010 |
Why?
|
Stainless Steel | 1 | 1969 | 80 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1995 | 969 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 1975 | 761 | 0.010 |
Why?
|
Pain Measurement | 1 | 1999 | 3420 | 0.010 |
Why?
|
Histoplasmosis | 1 | 1990 | 66 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1993 | 1950 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1993 | 930 | 0.010 |
Why?
|
Gallium Radioisotopes | 1 | 1990 | 178 | 0.010 |
Why?
|
Lung Diseases, Fungal | 1 | 1990 | 122 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1990 | 214 | 0.010 |
Why?
|
Extracorporeal Circulation | 1 | 1969 | 182 | 0.010 |
Why?
|
Communication | 1 | 2003 | 3749 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3340 | 0.010 |
Why?
|
Auscultation | 1 | 1988 | 42 | 0.010 |
Why?
|
Alleles | 1 | 2000 | 6933 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1989 | 878 | 0.010 |
Why?
|
Reimbursement Mechanisms | 1 | 1994 | 670 | 0.000 |
Why?
|
Heart Ventricles | 2 | 1993 | 3821 | 0.000 |
Why?
|
Behavior | 1 | 1991 | 561 | 0.000 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1990 | 365 | 0.000 |
Why?
|
Heart Block | 1 | 1969 | 410 | 0.000 |
Why?
|
Hip Prosthesis | 1 | 1994 | 917 | 0.000 |
Why?
|
Bradycardia | 1 | 1969 | 307 | 0.000 |
Why?
|
Cardiac Volume | 1 | 1988 | 210 | 0.000 |
Why?
|
Electrodes | 1 | 1969 | 619 | 0.000 |
Why?
|
Xenopus | 1 | 1989 | 712 | 0.000 |
Why?
|
Cognition | 1 | 1984 | 6770 | 0.000 |
Why?
|
Decision Trees | 1 | 1988 | 506 | 0.000 |
Why?
|
Respiration | 1 | 1993 | 1653 | 0.000 |
Why?
|
Chest Pain | 1 | 1993 | 1114 | 0.000 |
Why?
|
Hemodynamics | 1 | 1975 | 4199 | 0.000 |
Why?
|
Sarcoidosis | 1 | 1990 | 506 | 0.000 |
Why?
|
Bronchoscopy | 1 | 1990 | 862 | 0.000 |
Why?
|
Oocytes | 1 | 1989 | 1187 | 0.000 |
Why?
|
Equipment Failure | 1 | 1986 | 578 | 0.000 |
Why?
|
Intelligence Tests | 1 | 1984 | 505 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1989 | 4320 | 0.000 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1990 | 810 | 0.000 |
Why?
|
Rabbits | 1 | 1989 | 4894 | 0.000 |
Why?
|
Erectile Dysfunction | 1 | 1986 | 461 | 0.000 |
Why?
|
Bayes Theorem | 1 | 1990 | 2309 | 0.000 |
Why?
|
Lymphoma | 1 | 1990 | 1877 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1993 | 5097 | 0.000 |
Why?
|
Gene Expression | 1 | 1993 | 7799 | 0.000 |
Why?
|
Aorta | 1 | 1987 | 2061 | 0.000 |
Why?
|
Pneumonia, Viral | 1 | 1996 | 3240 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1988 | 2795 | 0.000 |
Why?
|
Preoperative Care | 1 | 1987 | 2250 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1989 | 13815 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1989 | 18111 | 0.000 |
Why?
|
Kidney Glomerulus | 1 | 1979 | 697 | 0.000 |
Why?
|
Complement System Proteins | 1 | 1979 | 795 | 0.000 |
Why?
|
Immunoglobulins | 1 | 1979 | 881 | 0.000 |
Why?
|
Learning | 1 | 1984 | 1713 | 0.000 |
Why?
|
Pulmonary Atelectasis | 1 | 1975 | 145 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1985 | 2569 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1975 | 530 | 0.000 |
Why?
|
Congenital Abnormalities | 1 | 1975 | 707 | 0.000 |
Why?
|
Cognition Disorders | 1 | 1984 | 4043 | 0.000 |
Why?
|
Pneumonectomy | 1 | 1975 | 1094 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1979 | 2104 | 0.000 |
Why?
|